KEY POINTS

  • Health experts and government officials were rallying round the AstraZeneca/University of Oxford vaccine on Monday after widespread concern following a small-scale trial that showed it offered “minimal protection” against mild disease caused by the South African variant of the virus.
  • With its vaccination drive falling far behind, the EU has finalized a deal with Pfizer and BioNTech for the supply of an additional 300 million doses of their Covid vaccine
  • Oil major Total reported a 2020 net profit of $4.06 billion, beating expectations of $3.86 billion but reflecting a 66% drop compared with $11.8 billion for the 2019 fiscal year.

European stocks were muted on Tuesday morning, bucking a positive trend seen in Asia and the U.S. at the start of the trading week.

The pan-European Stoxx 600 hovered fractionally below the flatline in early trade, with utilities and autos shedding 0.4% while oil and gas stocks added 0.3%.

The lackluster open in Europe comes despite a global rally on Monday that saw U.S. stocks hit record highs.

U.S. stock futures were little changed early Tuesday morning as Wall Street looked to hold on to gains from its February hot streak.

The move in futures comes after the three major indexes set another round of record highs on Monday. The Dow and S&P 500 have now advanced for six straight sessions, while the Nasdaq Composite has finished in the green on five of those six days.

Strong earnings and improving data on the Covid and vaccination front are among the factors helping to push stocks higher, analysts said. More major tech companies are set to report earnings stateside on Tuesday afternoon, including Twitter and Cisco.

Meanwhile in Europe, the coronavirus pandemic and vaccine rollout continue to dominate headlines and market sentiment. Health experts and government officials were rallying round the AstraZeneca/University of Oxford vaccine on Monday after widespread concern following a small-scale trial that showed it offered “minimal protection” against mild disease caused by the South African variant of the virus.

With its vaccination drive falling far behind, the EU has finalized a deal with Pfizer and BioNTech for the supply of an additional 300 million doses of their Covid vaccine, a European Commission spokesman told Reuters on Monday.

Earnings remain high on the agenda, with oil major Total reporting a massive fall in annual profit before the bell. Full-year 2020 net profit came in at $4.06billion, beating expectations of $3.86 billion, from analysts polled by Refinitiv, but reflecting a 66% drop compared with $11.8billion for the 2019 fiscal year.

On the data front, Norway consumer confidence, German current account figures and Italian industrial output figures for December are due.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.